These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21737582)

  • 1. Contrast-induced nephropathy in primary percutaneous coronary intervention.
    Gallagher S; Knight C
    Heart; 2011 Nov; 97(21):1723-5. PubMed ID: 21737582
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?
    Silvain J; Collet JP; Montalescot G
    Eur Heart J; 2014 Jun; 35(23):1504-6. PubMed ID: 24722806
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention.
    Marenzi G; De Metrio M; Rubino M; Lauri G; Cavallero A; Assanelli E; Grazi M; Moltrasio M; Marana I; Campodonico J; Discacciati A; Veglia F; Bartorelli AL
    Am Heart J; 2010 Dec; 160(6):1170-7. PubMed ID: 21146674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; You SJ; Wu YJ; Gao RL
    Int J Cardiol; 2008 Jun; 126(3):435-6. PubMed ID: 17462753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous transluminal coronary angioplasty, x-ray contrast researches and contrast-induced nephropathy in geriatrics].
    Chesnokov AA; Ar'ev AL; Ar'eva GT
    Adv Gerontol; 2013; 26(4):679-84. PubMed ID: 24738259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast induced nephropathy in patients with pre-existing renal impairment undergoing coronary angiogram and percutaneous transluminal coronary angioplasty.
    Subedi B; Siddique MA; Zaman SM; Hasan MI; Arzu J; Awal A; Fatema K
    Mymensingh Med J; 2011 Apr; 20(2):270-4. PubMed ID: 21522099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: contrast-induced acute kidney injury: shifting from elective to urgent coronary intervention.
    McCullough PA
    J Interv Cardiol; 2010 Oct; 23(5):467-9. PubMed ID: 20731756
    [No Abstract]   [Full Text] [Related]  

  • 10. Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency.
    Bokhari SW; Wen YH; Winters RJ
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):358-61. PubMed ID: 12594702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of red cell distribution width and contrast-induced acute kidney injury in percutaneous coronary interventions.
    Nichols EL; Brown JR
    Coron Artery Dis; 2015 Jun; 26(4):283-5. PubMed ID: 25909175
    [No Abstract]   [Full Text] [Related]  

  • 12. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "CIN" no more: the use of contrast volume to e-GFR ratio to predict and prevent contrast-induced acute kidney injury.
    Yu J; Mehran R
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1201-2. PubMed ID: 22234921
    [No Abstract]   [Full Text] [Related]  

  • 14. Remote-conditioning ischemia provides a potential approach to mitigate contrast medium-induced reduction in kidney function: a retrospective observational cohort study.
    Whittaker P; Przyklenk K
    Cardiology; 2011; 119(3):145-50. PubMed ID: 21952203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More contrast, no more brightness.
    Tortoledo F
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):344-5. PubMed ID: 12822154
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial.
    Guerchicoff A; Stone GW; Mehran R; Xu K; Nichols D; Claessen BE; Guagliumi G; Witzenbichler B; Henriques JP; Dangas GD
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):335-42. PubMed ID: 25130788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of complications after percutaneous coronary interventions with statins].
    Mega S; Nusca A; Patti G
    Recenti Prog Med; 2012 Jan; 103(1):5-10. PubMed ID: 22322620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.